Embolic Protection Devices: Are Filters Silent Stroke Predictors?

Slides:



Advertisements
Similar presentations
Ghanem et al., J Am Coll Cardiol 2010;55:1427–32..
Advertisements

Learn neurology “stroke by stroke.” C.M.Fisher. History Wepfer was the first in 1658, to recognize the significance of carotid obstruction and its relationship.
ACST-2 Ophthalmic sub-study Athanasios D. Giannoukas MD, MSc(Lond.), PhD(Lond.), FEBVS Professor of Vascular Surgery Chairman, Dept. of Vascular Surgery,
Endovascular Management of Intracranial and Extracranial Atherosclerosis Rishi Gupta, MD Associate Professor of Neurology, Neurosurgery, and Radiology.
Simultaneous Coronary Artery Bypass and Carotid Endarterectomy Ye zhidong, Liu Peng Department of Cardiovascular Surgery China-Japan Friendship Hospital.
Carotid Artery Stenosis: Stenting vs. Endarterectomy Városmajor Study. L. Entz,, E.Dósa, K. Hüttl. Department of Cardiovascular Surgery, Semmelweis University,
Proxis Proximal embolic protection in saphenous vein graft and infarct PCI Dan Blackman Leeds General Infirmary Advanced Angioplasty 2006.
Epidemiology in HK  Stroke is major cause of morbidity and mortality around the world  4th cause of mortality in HK resulting in >3000 deaths every.
Cerebrovascular Disease 2/22/06 Basic Science. Which of the following contributes to ischemic strokes: 1) Embolization of atherosclerotic and thrombotic.
Vascular D&C M. Uchiyama02/01/2013. Introduction  Complication  R MCA distribution embolic stroke  Procedure  R carotid angiography with planned,
ProximAl pRotection with the MO.MA device dUring caRotid stenting proximAl pRotection with the MO.MA device dUring caRotid stenting Barry T. Katzen MD.
UPDATE IN CAROTID ARTERY STENTING & STROKE MANAGEMENT Dr. Nikolaos Melas, PhD Vascular and Endovascular Surgeon Military Doctor Associate in 1st department.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
Columbia University Medical Center The Cardiovascular Research Foundation Temporal Improvement in Carotid Stent Outcomes: Achievement of AHA Target Goals.
Dr. Meg-angela Christi M. Amores
New embolic cerebral lesions detected with diffusion-weighted imaging after carotid artery and intracranial stent placement YH Chen, CJ Chen, DC Chen,
: PROFI : A Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Filter Embolic Protection in Patients Undergoing Carotid Stenting Klaudija.
Departments of Neurosurgery 1, Cardiology 2, Radiology 3, Gifu University Graduate School of Medicine, Gifu, Japan. Kiyofumi Yamada 1, Shinichi Yoshimura.
CAROTID ARTERY ENDARTHERECTOMY &INTERVENTION
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
Stents implantation to treat carotid lesions Lessons learned in the last 17 years Hugo Londero MD Córdoba-Argentina.
Embolic Protection Devices in Transcatheter Aortic Valve Replacement: Are We Barking Up the Wrong Vascular Tree? Circulation: cardiovascular intervention.
Open cervical approach for carotid artery stenting
(p for noninferiority = 0.01)
UPDATE IN CAROTID ARTERY STENTING & STROKE MANAGEMENT
Renal Embolic Protection: When and How ?
CAROTID STENTING: Step-by-Step Technique
William A. Gray, MD DISCLOSURES Consulting Fees
What´s New in the Literature on Transradial Intervention
Direct Carotid Access for Acute Stroke Intervention
Acute Carotid Occlusions
Complex Ostial Disease of the Aortic Arch Vessels
Claret Cerebral Protection Device: Implications of the Sentinel Study
(DES)+BVS +DCB for long diffuse LAD disease
Carotid Artery Stenting Predictors of procedural and clinical success
Restenosis in Peripheral Arteries
Cardiovascular Research Technology Conference (CRT 17)
L. Nelson Hopkins, MD DISCLOSURES Consulting Fees
Rabih A. Chaer MD Assistant Professor of Surgery
Risk of post-operative stroke in patients with known extra-cranial carotid artery disease undergoing Non-Cardiac Surgery Heart and Vascular.
Diagnostic Medical Sonography Program
Carotid Artery Stenting for Stroke Prevention
PMA Analysis of the CREST Trial Approvability of the RX Acculink Carotid Stent System for Revascularization of Carotid Artery Stenosis in Standard Surgical.
Hemodynamic Consequences of Cerebral Vasospasm on Perforating Arteries
Impact of calcium on procedural and clinical outcomes in lesions treated with bioresorbable vascular scaffolds - A prospective BRS registry study  Jiang.
Cerebral hyperperfusion syndrome after endovascular covered stent grafting for a giant extracranial aneurysm of the internal carotid artery  Sakyo Hirai,
The value of 3D-CT angiographic assessment prior to carotid stenting
Value of single photon emission computerized imaging in the treatment of patients undergoing carotid endarterectomy  Roy L. Tawes, MD, Robert Lull, MD 
Target lesion ulceration and arch calcification are associated with increased incidence of carotid stenting-associated ischemic lesions in octogenarians 
Median total new lesion volume
Current update of cerebral embolic protection devices
Carotid Artery Stenting for Stroke Prevention
Efficacy of a filter device in the prevention of embolic events during carotid angioplasty and stenting: An ex vivo analysis  Takao Ohki, MD, Gary S.
Status Update from ACST-2
Clinical significance of embolic events in patients undergoing endovascular femoropopliteal interventions with or without embolic protection devices 
Maureen M. Tedesco, MD, Jason T. Lee, MD, Ronald L
Determining the quantity and character of carotid artery embolic debris by electron microscopy and energy dispersive spectroscopy  Brian G. DeRubertis,
John Ochsner Heart and Vascular Institute
Preoperative risk factors for carotid endarterectomy: defining the patient at high risk  Amy B Reed, MD, Peter Gaccione, MA, Michael Belkin, MD, Magruder.
Philip P. Goodney, MD, Donald S. Likosky, PhD, Jack L. Cronenwett, MD 
Ex vivo human carotid artery bifurcation stenting: Correlation of lesion characteristics with embolic potential  Takao Ohki, MD, Michael L. Marin, MD,
The value of 3D-CT angiographic assessment prior to carotid stenting
Heparin versus bivalirudin for carotid artery stenting using proximal endovascular clamping for neuroprotection: Results from a prospective randomized.
Evaluation of carotid artery outward remodeling by T1-weighted magnetic resonance imaging in carotid endarterectomy and stenting  Daisuke Maruyama, MD,
Daniel S. Kassavin, MD, Daniel G. Clair, MD 
Carotid endarterectomy and intracranial thrombolysis: Simultaneous and staged procedures in ischemic stroke  Hans-Henning Eckstein, MD, Hardy Schumacher,
Antonio V. Sterpetti, MD, Richard D. Schultz, MD, Richard J
Hans H. Tulip, MD, Eric B. Rosero, MD, Adriana J
Concomitant asymptomatic internal carotid artery and persistent primitive hypoglossal artery stenosis treated by endovascular stenting with proximal embolic.
Craig R. Narins, MD, Karl A. Illig, MD  Journal of Vascular Surgery 
Presentation transcript:

Embolic Protection Devices: Are Filters Silent Stroke Predictors? CRT 2010 Embolic Protection Devices: Are Filters Silent Stroke Predictors? Michael Wholey, MD, MBA Central Cardiovascular Institute 2/23/10 8:50- 9:00 AM

Michael H. Wholey, MD DISCLOSURES I have no real or apparent conflicts of interest to report. I intend to reference unlabeled/ unapproved uses of drugs or devices in my presentation. I intend to reference carotid stenting and filter devices.

Financial Disclosures I have no financial interests in this area.

Basic Questions 1. Are Carotid Embolic Protection Devices Helpful ?

Some questions are intuitive.

What Would This Large (Calcified) Embolic Particle Do In the Cerebral Circulation If It Had Not Been Captured ?

How Often Is There Visable Debris in the Filter Basket ? Ouriel et al 90 Angioguard 54% Lupatelli 96 Trap/EPI 21% Sprouse 279 60% Bosiers 100 EPI 57% Reimers 84 3 types 53% Angelini 37 84% There was an increased risk of visible debris found with hypertension, hypercholesterolemia, stent diameter >9 mm, and any neurologic event Collected material consisted of lipid-rich macrophages, fibrin material, and cholesterol clefts.

Carotid Stenting With and Without Protection Symptomatic Pts Asymptomatic Pts 6.04% 3.97% 2.70% 1.75%

CAS with and without DP Author With DP Results Without DP Reduction Zahn Eur Heart J. 2004 Sep;25(17):1550-8. 668 (45%) 2.1% Stroke and Death 676 (55%) 4.9% Stroke and Death 57% Castriota Endovasc Ther. 2002 Dec;9(6):786-92. 150 (55%) 0.7% Stroke 125 (45%) 2.4% Stroke 79% EVA-3 Stroke. 2004 Jan;35(1):e18-20. 58 8% Stroke 15 27% Stroke 70% KASTROP Stroke. 2003 Mar;34(3):813-9. 896 (literature review) 1.8% Stroke and Death 2537 5.5% Stroke and Death 67% Roubin 6.9% Stroke and Death 74% * All Statistically significant

Basic Questions 1. Are Carotid Embolic Protection Devices Helpful ? 2. Are Distal Protection Devices Silent Predictors for Stroke ?

Silent Cerebral Ischemia with DPD Jaeger et al. The Angioguard filter device was effectively employed in 16 of 20 pts New ipsilateral cerebral lesions were visualized by DW-MRI in 3 of the 20 procedures No new permanent neurologic deficits occurred. Cardiovasc Intervent Radiol 2001 Jul-Aug;24(4):249-56 Schluter et al 42 consecutive patients using six types of cerebral protection systems New ischemic foci were seen on postinterventional MRI in 10 cases (22.7%). One patient had sustained a major stroke, whereas no adverse neurological sequelae were associated with the other nine procedures J Am Coll Cardiol. 2003 Sep 17; 42(6): 1007-13

Silent Ischemia with DP METHODS: 67 CAS were performed with EPI The mean length of the procedure was 22.2 minutes (range 8-110). All patients had a cerebral MRI done in the 3 days before CAS and a DW-MR was done the day after. RESULTS: 30-Day Events: 3 TIA’s, 1 minor stroke (1.5%) on day 21, but no major stroke, death or MI DW-MRI after CAS showed 26 new silent ischemic lesions in 11 asymptomatic patients (16.4%). 6 Pts , they were multiple (range 2-5). Location: 21 ipsilateral MCA, 4 in the posterior fossa, and 1 in the contralateral MCA. Gonzales Neurol Res. 2005;27 Suppl 1:S79-83.

Diffusion Weighted MRI Post CAS New ischemic foci were observed in 17.3% of the patients undergoing neuroprotected CAS. Appearance of new ischemic lesions were only significantly related to the occurrence of TIA but not to the number of MES registered or other variables. Incidence of new brain lesions after carotid stenting with and without cerebral protectionA. Kastrup, T. Nagele and K. Groschelet al. Stroke 2006; 36:2312-6.. 

MRI Diffusion Weighted Studies in Post Endarterectomy Postoperative DWI revealed ipsilateral ischemic lesions in 15 patients (17%). In seven of these patients a brain infarction was diagnosed on the T1-MRI during follow-up. A significant correlation between the number of DWI lesions (p=0.031) as well as the volume of DWI lesions (p=0.023) and definite infarction was found. Symptomatic patients preoperatively showed significantly more DWI lesions (p=0.036) and cerebral infarcts (p=0.003) Wolf et al Frequency, Clinical Significance and Course of Cerebral Ischemic Events after Carotid Endarterectomy Evaluated by Serial Diffusion Weighted Imaging European Journal of Vascular and Endovascular Surgery, Volume 27, Issue 2, Pages 167-171

Silent Cerebral Ischemia Detected by Diffusion-Weighted MRI After Carotid Endarterectomy A Preoperative brain DWI of a 74-year-old woman with an asymptomatic high-grade carotid stenosis on the right side. B, Postoperative brain DWI demonstrating a single new hyperintensity in the ipsilateral subcortical temporal region (arrow), which was highly suggestive of a perioperative embolusAsymptomatic Courtesy of Alain Barth (Stroke. 2000;31:1824.)

Diffusion Weighted CAS Studies Author Patients Stroke & Death MRI Findings(ipsilateral) Kastrup et al 139 Protected 4.3% 49% 67 Unprotected 7.5% 67% Piñeroa et al 162 protected 28 pts (17.3%) single foci 13 pts (8%) multiple foci Wolf et al. 88 Protected 2.3% 15 (17%) Gossetti et al 50 CAS 50 CEA 4% 2% 24 (44%) 2 (4%) Schnaudigel et al 1363 CAS 753 CEA -- 37% 10%

So what does this silent ischemia mean ? Are our filters truly effective ? Are we releasing too many small particles? Failing to capture (and hang on) to larger ones?

So what does this silent ischemia mean ? Are our filters truly effective ? Are we releasing too many small particles? Failing to capture (and hang on) to larger ones? Procedural Questions ? Too much manipulations in the aortic arch ? Evidenced by the incidence of post fossa and contralateral hits Excessive Time of procedures

Basic Questions 1. Are Carotid Embolic Protection Devices Helpful ? 2. Are Distal Protection Devices Silent Predictors for Stroke ? 3. Are all Distal Protection Devices the Same ?

Four appproved DPFs (Spider RX, FilterWire EZ, RX Accunet, and FiberNet) were evaluated in a pulsatile programmable piston pump circulated a blood analog at a time-varying flow rate representative of the human common carotid artery. A silicone carotid bifurcation having average human dimensions was used for the carotid flow model. Microspheres ranging from 40 to 900 µm were injected to simulate embolization. The longitudinal vascular impedance was calculated as the ratio of the time-varying pressure gradient across the DPF to the time-varying flow rate in the internal carotid artery.

In Vitro Study

In Vitro Study: Capture Efficiency -RX Accunet had the highest capture efficiency (99.4%) and Spider RX had the lowest (78.1%). -Spider RX missed the largest average number of small particles (14.6) and RX Accunet missed the fewest small particles (0.2). -All 4 DPFs missed a similar average number of medium sized particles (range 0.1–0.4). -All DPFs captured all large particles.

In Vitro Study: Vascular Impedance An increase in longitudinal vascular impedance indicated an increase in pressure gradient and decrease in flow rate. -Spider RX had the smallest increase in longitudinal vascular impedance in EF closely followed by FilterWire EZ . -FiberNet had the largest increase in longitudinal vascular impedance for both EF and FF.

In Vitro Study of the Filters Results: Capture Efficiency: RX Accunet had the highest capture efficiency (99.4%) and Spider RX the lowest (78.1%). Vascular Impedance: Spider RX increased the longitudinal vascular impedance the least after deployment (+23%), while FilterWire EZ increased the longitudinal vascular impedance the least after particles were injected (+29%). FiberNet increased longitudinal vascular impedance the most (+84%).

What is the debris ? The 2 main debris types found were nonrefringent cholesterol crystals (4 to 389 micron) and lipoid masses (7 to 600 micron). Martin et al. Stroke 2001 Feb;32(2):479-84 The 22 to 667 particles aspirated per patient, mean 203 micron)…included fibrous plaque debris, lipid or cholesterol vacuoles, and calcific plaque fragments Whitlow et al. Stroke 2002 May;33(5):1308-14

Potential Problems with Distal Protection Inability to deliver or deploy the device  Large device profile  Lack of steerability  Excessive vessel tortuosity Device-induced complications  Injury to the internal carotid artery from the guidewire or protection device  Embolization due to passage of the device through the lesion Cerebral ischemia  Patient intolerance due to balloon occlusion  Filters may become packed with debris causing flow limitations Incomplete capture or retrieval of debris  Pores in filter may allow passage of small particulate debris  Burden of debris may overwhelm the protection device  Incomplete apposition of device to carotid wall may allow embolization Embolization into proximal branches  External carotid (ophthalmic artery)

Potential Problems with Distal Protection Inability to deliver or deploy the device  Large device profile  Lack of steerability  Excessive vessel tortuosity Device-induced complications  Injury to the internal carotid artery from the guidewire or protection device  Embolization due to passage of the device through the lesion Cerebral ischemia  Patient intolerance due to balloon occlusion  Filters may become packed with debris causing flow limitations Incomplete capture or retrieval of debris  Pores in filter may allow passage of small particulate debris  Burden of debris may overwhelm the protection device  Incomplete apposition of device to carotid wall may allow embolization Embolization into proximal branches  External carotid (ophthalmic artery)

Common Filter Problem: Spasm

Problems with Filters: Dissection

Full Basket Following Advancement Across Lesion

Basic Questions 1. Are Carotid Embolic Protection Devices Helpful ? 2. Are Distal Protection Devices Silent Predictors for Stroke ? 3. Are all Distal Protection Devices the Same ? 4. Are Proximal Occlusion Devices Better?

Conclusions There exists differences among the various carotid filters Filters and the inability to capture embolic debris can help lead to silent cerebral ischemia detected by diffusion-weighted MRI